INDSWFTLTDPharmaceuticals & Biotechnology
Ind Swift — PE Ratio & Valuation Analysis
₹15.76
+0.00%
Current P/E11.80xPrice to earnings
Industry P/E33.56xSector average
4Y Avg P/E5.6x112.0% above avg
✅
64.8% Discount to Industry
INDSWFTLTD P/E 11.80x vs sector avg 33.56x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹52.33 | ₹16 | 0.3x |
| 2024 | ₹2.63 | ₹33 | 12.6x |
| 2023 | ₹4.81 | ₹18 | 3.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Ind Swift Valuation
Ind Swift (INDSWFTLTD) currently trades at 11.80x earnings. The Pharmaceuticals & Biotechnology sector average PE is 33.56x. INDSWFTLTD is trading at a discount to peers — may indicate relative value. Historically, INDSWFTLTD has traded at an average PE of 5.6x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
N/A
Dividend Yield
0.00%
More on Ind Swift
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.